Malignancy-associated risk factors in patients with systemic sclerosis
In the current study, advanced age at systemic sclerosis diagnosis was determined to be an extra risk factor for the initiation of cancer in systemic sclerosis patients. Particularly in this patient group, additional screenings might be helpful for early diagnosis. Treatments such as methotrexate, cyclophosphamide, azathioprine, and mycophenolate mofetil can be used without additional cancer risk.
Authors
- Serdar Baysal (ORCID: https://orcid.org/0000-0003-3394-2005)
- D. Sahin Eroglu (ORCID: https://orcid.org/0000-0003-3558-5400)
- Aşkın Ateş (ORCID: https://orcid.org/0000-0003-1966-3333)
- T. M. Turgay
- Gülay Kınıklı (ORCID: https://orcid.org/0000-0002-4006-1022)
- M.E. Yayla
- Serdar Sezer (ORCID: https://orcid.org/0000-0001-5401-5599)
- Emine Uslu (ORCID: https://orcid.org/0000-0002-4717-3000)
Institutions
- Ankara University (TR)
Publication Details
- Journal
- Journal of Scleroderma and Related Disorders
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1177/23971983251322841
- Citations
- 1
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47